CAT
Caterpillar Inc.
CAT has the edge over SNT overall, supported by stronger modeled upside and lower modeled downside.
SNT
Senstar Technologies Ltd.
SNT trails on the overall score without a compensating advantage in the available component scores.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
SNT's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over SNT in the historical PE scenario, which offers more potential upside but is not a forecast.
SNT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.2x | $0.16 | -92% |
| Fair | 22x | $0.44 | -78% |
| Expensive | 60x | $1.20 | -41% |
| Current | 113x | $2.03 | — |
Historical ranges are pointers, not guarantees.
SNT's PE is in its expensive range at 113x.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
SNT Forward outlook
There aren't enough analyst estimates for SNT to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
SNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.02 | -91% |
| Q1 2026 | $0.05 | -74% |
| Q4 2025 | $0.13 | +18% |
| Q3 2025 | $0.20 | +233% |
| Q2 2025 | $0.22 | +$0.22 |
| Q1 2025 | $0.19 | +$0.20 |
| Q4 2024 | $0.11 | +$0.17 |
| Q3 2024 | $0.06 | -14% |
SNT has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over SNT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over SNT on profitability, with a higher operating margin.
SNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $10.4M | +8.2% |
| Q1 2026 | $8.1M | -4.3% |
| Q4 2025 | $8.8M | -14% |
| Q3 2025 | $9.5M | -2.1% |
| Q2 2025 | $9.7M | +16% |
| Q1 2025 | $8.4M | +12% |
| Q4 2024 | $10.2M | +15% |
| Q3 2024 | $9.7M | +8.2% |
SNT's revenue is recovering but still below its 2020 peak: $10M last quarter, up 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 3.3% | -6.8 points |
| Q1 2026 | -7.5% | -20 points |
| Q4 2025 | -1.8% | -16 points |
| Q3 2025 | 12% | -6.7 points |
| Q2 2025 | 10% | +2.1 points |
| Q1 2025 | 12% | +13 points |
| Q4 2024 | 14% | +11 points |
| Q3 2024 | 19% | +17 points |
SNT's operating margin was 3.3% last quarter, down 6.8 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over SNT on cash flow, with more consistent year-over-year improvement.
SNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $1.2M | +$1.2M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
SNT's free cash flow has been positive every quarter for seven years: $1M over the past year, against $0 the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over SNT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
SNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -4.2K shares |
| 3 years | +0.1% | +21.7K shares |
| 5 years | +0.7% | +168K shares |
| Available history | +0.7% | +165K shares |
SNT has 23M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
SNT hasn't bought back shares in the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
SNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.8x | Net Cash |
| Q1 2026 | -5.1x | Net Cash |
| Q4 2025 | -5.8x | Net Cash |
| Q3 2025 | -4.1x | Net Cash |
| Q2 2025 | -3.7x | Net Cash |
| Q1 2025 | -3.7x | Net Cash |
| Q4 2024 | -4.2x | Net Cash |
| Q3 2024 | -5.5x | Net Cash |
SNT has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 53.4 | Neutral |
SNT's weekly RSI is 51 (neutral) and its Stochastic is 53 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over SNT on valuation relative to its sector.
SNT PE vs Industrials Sector
| Metric | SNT | Sector median | Relative |
|---|---|---|---|
| PE | 113x | 24x | 371% above |
| PE % | 85 | 58 | 27 pts above |
SNT is trading at 113x earnings, a 371% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
SNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.62 | 25% above |
| 20 week MA | $1.69 | 20% above |
| 50 week MA | $2.62 | 23% below |
| 100 week MA | $3.32 | 39% below |
| 200 week MA | $2.38 | 15% below |
SNT has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 15% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over SNT on returns for 2026, with the stronger performance.
SNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.73 | $5.09 | +36% |
| 2021 | $5.09 | $2.98 | -41% |
| 2022 | $2.98 | $1.37 | -54% |
| 2023 | $1.37 | $1.29 | -5.8% |
| 2024 | $1.29 | $3.55 | +175% |
| 2025 | $3.55 | $4.45 | +25% |
| 2026 YTD | $4.45 | $2.03 | -54% |
SNT's yearly returns have swung widely, from +175% in 2024 to −54% in 2022. It's down 54% so far in 2026.